trans-Dichlorodiamineplatinum(II) CAS:14913-33-8

In medicinal chemistry, trans-Dichlorodiamineplatinum(II) is well-known for its use as an anticancer drug. It is a key component of the chemotherapy drug cisplatin, which is used to treat various forms of cancer, including testicular, ovarian, and bladder cancers. Its ability to bind to DNA and interfere with cell division makes it an important tool in cancer treatment. In catalysis, trans-Dichlorodiamineplatinum(II) has been explored for its applications in organic synthesis. It has been used as a catalyst in various chemical reactions, including the formation of carbon-carbon bonds, the functionalization of organic molecules, and the synthesis of complex organic compounds. Its high catalytic activity and selectivity make it an important catalyst in the development of efficient and sustainable chemical processes. In materials science, trans-Dichlorodiamineplatinum(II) has been investigated for its potential use in the development of platinum-containing materials with applications in catalysis, sensing, and electronic devices. Research efforts have focused on using this compound to develop platinum-based materials such as nanoparticles, thin films, and coordination polymers for various technological applications. In summary, trans-Dichlorodiamineplatinum(II) exhibits potential applications in medicinal chemistry, catalysis, and materials science. Its unique coordination environment and reactivity make it a subject of interest for the development of new cancer treatments, catalytic systems, and functional materials.